arginine vasopressin has been researched along with Left Ventricular Dysfunction in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (50.00) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyd, JH; Indrambarya, T; McConechy, M; Walley, KR; Wang, Y | 1 |
Asfar, P; Radermacher, P | 1 |
Akahoshi, Y; Fujiki, H; Iwanaga, Y; Miyazaki, S; Morooka, H; Nakano, Y; Takase, T; Tamaki, Y | 1 |
Clunie, S; Denfield, SW; Dreyer, WJ; McMahon, CJ; Price, JF; Radovancevic, B; Smith, EO; Towbin, JA | 1 |
Benedict, CR; Francis, GS; Greenberg, B; Johnstone, DE; Kirlin, P; Konstam, MA; Kubo, SH; Liang, CS; Nicklas, J; Shelton, B | 1 |
Benedict, C; Francis, G; Johnstone, D; Kirlin, PC; Kubo, S; Liang, CS; Nicklas, J; Probstfield, J; Shelton, BJ; Yusuf, S | 1 |
Ahn, S; Benedict, CR; Bornemann, M; Melin, J; Pouleur, H; Raphaël, D; Rousseau, MF | 1 |
Abe, K; Johnston, CI; Kanazawa, M; Kohzuki, M; Sato, T; Tsutsumi, E; Yasujima, M; Yoshida, K | 1 |
Cosín Aguilar, J; Cruz Fernández, JM; de Teresa Galván, E; Ferreira Montero, IJ; López-Sendón, J; Soler Soler, J; Tamargo Menéndez, J | 1 |
Lerch, R; Montessuit, C | 1 |
Doughty, R; Espiner, EA; Frampton, C; Ikram, H; Macmahon, S; Nicholls, MG; Richards, AM; Sharpe, N; Yandle, TG | 1 |
Cohn, JN | 1 |
Anderson, AS; Ward, RP | 1 |
Groenning, BA; Hildebrandt, PR; Kjaer, A; Larsson, HB; Nilsson, JC; Sondergaard, L | 1 |
4 review(s) available for arginine vasopressin and Left Ventricular Dysfunction
Article | Year |
---|---|
[Neurohormonal factors in heart failure. II].
Topics: Arginine Vasopressin; Cardiotonic Agents; Death, Sudden, Cardiac; Diuretics; Endothelins; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Prognosis; Prostaglandins; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left | 1996 |
[Hypertrophy due to left cardiac insufficiency: role of the neurohumoral system].
Topics: Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Heart Failure; Humans; Hypertrophy, Left Ventricular; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume; Systole; Ventricular Dysfunction, Left | 1997 |
Left ventricle and arteries: structure, function, hormones, and disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine Vasopressin; Drug Combinations; Epinephrine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroprusside; Prazosin; Randomized Controlled Trials as Topic; Renin; Renin-Angiotensin System; Stroke Volume; Survival Analysis; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2001 |
Slowing the progression of CHF. Drug therapy to correct neurohormonal abnormalities.
Topics: Adrenergic beta-Antagonists; Age Distribution; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Atrial Natriuretic Factor; Disease Progression; Family Practice; Heart Failure; Hemodynamics; Humans; Mineralocorticoid Receptor Antagonists; Primary Health Care; Renin-Angiotensin System; United States; Ventricular Dysfunction, Left | 2001 |
3 trial(s) available for arginine vasopressin and Left Ventricular Dysfunction
Article | Year |
---|---|
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators.
Topics: Aged; Analysis of Variance; Arginine Vasopressin; Canada; Chi-Square Distribution; Enalapril; Female; Follow-Up Studies; Humans; Male; Middle Aged; Natriuretic Agents; Norepinephrine; Regression Analysis; Renin; United States; Ventricular Dysfunction, Left | 1995 |
Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction.
Topics: Arginine Vasopressin; Atrial Natriuretic Factor; Coronary Circulation; Double-Blind Method; Echocardiography; Female; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Nisoldipine; Norepinephrine; Renin; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1994 |
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.
Topics: Arginine Vasopressin; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Double-Blind Method; Heart Failure; Humans; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Neuropeptides; Norepinephrine; Predictive Value of Tests; Prognosis; Propanolamines; Survival Analysis; Vasodilator Agents; Ventricular Dysfunction, Left | 1999 |
7 other study(ies) available for arginine vasopressin and Left Ventricular Dysfunction
Article | Year |
---|---|
Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.
Topics: Animals; Arginine Vasopressin; Cardiotonic Agents; Dobutamine; Heart Failure; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Shock; Stroke Volume; Survival Analysis; Vasoconstrictor Agents; Ventricular Dysfunction, Left | 2009 |
Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?
Topics: Arginine Vasopressin; Contraindications; Humans; Myocardial Ischemia; Vasoconstrictor Agents; Ventricular Dysfunction, Left | 2009 |
Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Blood Pressure; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Heart Failure; Hormone Antagonists; Hypertension; Kidney; Kidney Diseases; Male; Myocardium; Natriuretic Peptides; Rats; Rats, Inbred Dahl; Receptors, Vasopressin; RNA, Messenger; Sodium Chloride, Dietary; Time Factors; Tolvaptan; Ultrasonography; Urination; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Arginine vasopressin levels are elevated and correlate with functional status in infants and children with congestive heart failure.
Topics: Arginine Vasopressin; Cardiomyopathy, Dilated; Case-Control Studies; Child; Child, Preschool; Female; Heart Failure; Humans; Infant; Male; Pulmonary Circulation; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2004 |
Neurohumoral variability in left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction.
Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Disease Progression; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Randomized Controlled Trials as Topic; Renin; Supine Position; Ventricular Dysfunction, Left | 1995 |
Cardiomegaly and vasoactive hormones in rats with chronic myocardial infarction: long-term effects of chlorothiazide.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Cardiomegaly; Chlorothiazide; Chronic Disease; Diuretics; Female; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Sulfonamides; Time Factors; Ventricular Dysfunction, Left | 1996 |
Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.
Topics: Aged; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Endothelin-1; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Regression Analysis; Renin; Stroke Volume; Ventricular Dysfunction, Left | 2001 |